OPKO Health to Report Second Quarter 2026 Financial Results on July 27, 2026

Rhea-AI Summary

OPKO Health (NASDAQ: OPK) will report its second-quarter 2026 operating and financial results on Monday, July 27, 2026. Senior management will host a conference call and webcast at 4:30 p.m. ET, with live access via pre-registration or dial-in and replays available through early August 2026.

News Market Reaction – OPK

-0.85%

3 alerts

-0.85% Session close to close

$891.01M Market Cap

0.5x Rel. Volume

In the Jul 23 session, OPK declined 0.85%, reflecting a mild negative market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Prior earnings-date notices recorded +2.46% and -3.2% 24-hour reactions, producing a -0.37% average....

Analysis

Prior earnings-date notices recorded +2.46% and -3.2% 24-hour reactions, producing a -0.37% average. That mixed record adds context to this scheduling announcement; the subsequent financial guidance discussion remains a key watchpoint.

Key Figures

Results Reporting Date: July 27, 2026

1 metrics

Results Reporting Date July 27, 2026 Second-quarter 2026 operating and financial results

Previous Earnings date Reports

2 past events · Latest: Apr 21 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 21	Earnings date	Neutral	+2.5%	Announced Q1 2026 results date and management conference call timing
Feb 12	Earnings date	Neutral	-3.2%	Announced Q4 2025 results date and financial guidance discussion

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date announcements produced mixed 24-hour reactions of +2.46% and -3.2%, averaging -0.37%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MIAMI, July 23, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (OPKO) (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that it will report operating and financial results for the second-quarter 2026 on Monday, July 27, 2026. OPKO’s senior management will host a conference call and webcast at 4:30 p.m. ET to provide a business update, discuss results and financial guidance.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Participants who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed through OPKO’s Investor Relations here.

A telephone replay will be available until August 3, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 6858214. A webcast replay will be available beginning approximately one hour after the completion of the live conference call through OPKO’s Investor Relations here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

Alliance Advisors IR
Vivian Cervantes, 973-873-7724
vcervantes@allianceadvisors.com

FAQ

When will OPKO Health (NASDAQ: OPK) report its Q2 2026 financial results?

OPKO Health will report its Q2 2026 operating and financial results on Monday, July 27, 2026. According to OPKO Health, the announcement will be accompanied by a management conference call and webcast held later that same afternoon at 4:30 p.m. ET.

What time is OPKO Health's Q2 2026 earnings conference call on July 27, 2026?

OPKO Health’s Q2 2026 earnings conference call is scheduled for 4:30 p.m. ET on July 27, 2026. According to OPKO Health, senior management will provide a business update, discuss results and offer financial guidance during the call and webcast.

How can investors access OPKO Health's (OPK) Q2 2026 earnings call and webcast?

Investors can access OPKO Health’s Q2 2026 call by pre-registering online to receive a unique PIN or dialing 833-630-0584 (U.S.) or 412-317-1815 (International). According to OPKO Health, a simultaneous webcast will be available via the company’s Investor Relations website.

Is there a replay available for OPKO Health's Q2 2026 earnings conference call?

Yes, a telephone replay will be available until August 3, 2026 by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) with passcode 6858214. According to OPKO Health, a webcast replay will begin about one hour after the live call ends.

Where can I find the webcast replay of OPKO Health's July 27, 2026 Q2 2026 earnings call?

The webcast replay of OPKO Health’s July 27, 2026 Q2 2026 earnings call will be available via the company’s Investor Relations website. According to OPKO Health, access will start approximately one hour after the completion of the live conference call.

What type of company is OPKO Health (NASDAQ: OPK)?

OPKO Health is a multinational biopharmaceutical and diagnostics company focused on next-generation solutions for serious diseases. According to OPKO Health, it aims to build industry-leading positions in large, fast-growing markets using its discovery, development, commercialization expertise and proprietary technologies.